No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract AMLSG 09-09: Adding getuzumab ozogamicin (GO) to intensive therapy for Nucleophosmin1 mutated acute myeloid leukemia (NPM1mut AML) leads to better NPM1mut transcript clearance and a lower replase rate

byKathleen Lau

January 15, 2021

in StudyGraphics

RELATED REPORTS

Chemotherapy exposure is independently associated with reduced pain severity in advanced pancreatic cancer

Spinal instability may be the primary cause of pain in sacral metastases as opposed to neurologic compromise

Enfortumab vedotin plus pembrolizumab is more effective than platinum-based chemotherapy in metastatic urothelial carcinoma

O and Rh– blood groups may be associated with decreased risk for SARS-CoV-2 infection

RelatedReports

Rectal indomethacin dose escalation for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography in high-risk patients

Chronic Disease

Chemotherapy exposure is independently associated with reduced pain severity in advanced pancreatic cancer

July 15, 2026

Epidural corticosteroid injections provide only short-term radiculopathy pain relief

Chronic Disease

Spinal instability may be the primary cause of pain in sacral metastases as opposed to neurologic compromise

July 14, 2026

Chronic Disease

Enfortumab vedotin plus pembrolizumab is more effective than platinum-based chemotherapy in metastatic urothelial carcinoma

July 9, 2026

Obstetric scoring systems overestimate cases of severe sepsis

All Specialties

2 Minute Medicine Rewind July 6, 2026

July 7, 2026

Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children

Convalescent plasma may not improve outcomes in Covid-19 patients

SARS-CoV-2 detected on various surroundings of asymptomatic COVID-19 positive infant

Hydroxychloroquine may not prevent Covid-19 after contact exposure

#VisualAbstract: Every-other-day dosing of oral rimegepant is effective for preventive treatment of migraines

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result